Lpath Inc (NASDAQ:LPTN)
| 4.57 Data as of Jun 18 |  -0.08 / -1.72%Today’s Change | 4.13 Today|||52-Week Range 7.01 | -9.50% Year-to-Date |
Latest LPTN News | Press Releases
No recent news for Lpath Inc.
Today’s Trading
| Previous close | 4.65 |
| Today’s open | 4.64 |
| Day’s range | -- - -- |
| Volume | 1,901 |
| Average volume (3 months) | 21,739 |
| Market cap | $61.0M |
| Dividend yield | -- |
Data as of 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +25.71% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -28.75% |
| P/E ratio | NM |
| Price/Sales | 8.11 |
| Price/Book | 4.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYTRCytRx Corp | +0.01 | +0.47% |
| CLSNCelsion Corp | +0.10 | +8.26% |
| DRIOLabStyle Innovations... | -0.19 | -6.91% |
| PIPPharmAthene Inc | +0.01 | +0.64% |
Data as of 4:01pm ET, 06/18/2013
Financials
| Last reporting date | June 19, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $6.7M |
| Annual profit (last year) | -$2.8M |
| Net profit margin | -41.15% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Scott R. Pancoast, MBA |
Chief Financial Officer, Secretary & Senior VP Gary J. G. Atkinson, CPA |
Corporate headquarters San Diego, California |
Forecasts
